EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diagnostic value of metagenomic next-generation sequencing in patients with febrile lung cancer with negative conventional microbiological tests and without neutropenia

Changjian Wang, Mengyun Min, Zhendong Dai, Geng Wang, Yangchenxi Wang, Ting Hu, Yuxi Ma, Sheng Zhang, Chuangyan Wu, Rui Zhou

Frontiers in Cellular and Infection Microbiology · 13.03.2026 · 16

DOI: 10.3389/fcimb.2026.1715563 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 13.03.2026. Verfasst von Changjian Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: High-Throughput Nucleotide Sequencing, Metagenomics, Lung Neoplasms, Fever. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hubei Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Fever in nonneutropenic lung cancer often remains microbiologically unresolved because of the limitations of conventional microbiological tests (CMT). We assessed whether plasma metagenomic next-generation sequencing (mNGS) improves diagnostic yield and accelerates defervescence in these patients.

Methods

We retrospectively analyzed 53 CMT-negative febrile lung cancer patients (August 2023–October 2024). Patients were classified into high-suspicion infectious fever (HSIF) or high-suspicion tumor fever (HSTF) groups based on mNGS results, and clinical management was adjusted accordingly. Results mNGS identified pathogens in 69.8% (37/53) of patients, commonly including Epstein–Barr virus , Mycobacterium tuberculosis , and Candida albicans . Patients in the HSIF group showed significantly higher baseline inflammatory markers than those in the HSTF group. Importantly, following mNGS-guided antimicrobial therapy, the HSIF group achieved significantly higher defervescence rates at 48 h (73.0% vs . 37.5%; p = 0.029) and 96 h (89.2% vs . 68.8%; p = 0.027) compared to the HSTF group.

Discussion

In conclusion, in CMT-negative, nonneutropenic febrile lung cancer, plasma mNGS significantly increases pathogen detection and informs antimicrobial decisions associated with earlier defervescence, although interpretation is limited by the retrospective design and lack of an independent gold standard.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

High-Throughput Nucleotide SequencingMetagenomicsLung NeoplasmsFeverHumansRetrospective StudiesFemaleMaleAgedMiddle AgedNeutropenia

Stichwörter der Autor:innen

blood culturediagnosisinfectious feverlung cancermetagenomic next-generation sequencing (mNGS)non-neutropenic

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Department of Oncology, The Second People's Hospital of China Three Gorges University, Yichang, China.
  • Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Institute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Hubei Key Laboratory of Precision Radiation Oncology, Wuhan, China.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Hubei Province

Zitieren

APA

Wang, C., Min, M., Dai, Z., Wang, G., Wang, Y., Hu, T., Ma, Y., Zhang, S., Wu, C., & Zhou, R. (2026). Diagnostic value of metagenomic next-generation sequencing in patients with febrile lung cancer with negative conventional microbiological tests and without neutropenia. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1715563

Vancouver

Wang C, Min M, Dai Z, Wang G, Wang Y, Hu T, et al. Diagnostic value of metagenomic next-generation sequencing in patients with febrile lung cancer with negative conventional microbiological tests and without neutropenia. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1715563

BibTeX
@article{Wang2026,
  author = {Wang, Changjian and Min, Mengyun and Dai, Zhendong and Wang, Geng and Wang, Yangchenxi and Hu, Ting and Ma, Yuxi and Zhang, Sheng and Wu, Chuangyan and Zhou, Rui},
  title = {Diagnostic value of metagenomic next-generation sequencing in patients with febrile lung cancer with negative conventional microbiological tests and without neutropenia},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fcimb.2026.1715563}
}
Kostenlos starten →